Seeding and scaling Ontario’s premiere entrepreneurial ventures for patients and the economy.
Increasing the value of Ontario’s best oncology innovations and attracting investment from the private sector (current as of November 2021).
In total funding and equity investments
In additional financing attracted
Ontario start-ups created
Our investments are at the forefront of Ontario’s biotech ecosystem.
Our investments bridge the life sciences seed funding gap.
Our investments have resulted in significant partnerships, clinical trials, job creation and leveraged financing for the province.
Keep up to date on our investments and business developments in recent news stories and summaries.
January 11, 2022 – Now in its 9th year, the FACIT Falcons’ Fortunes event is back for 2022! Be part of the audience and watch the six finalists pitch their Ontario oncology innovations.
January 11, 2022 – Having recently announced several collaborations following the closing of a financing round with Nina Capital, Replica has significant momentum behind it.
November 30, 2021 – The appointment broadens the available expertise to provide critical senior management and leadership to create and nurture FACIT start-ups in Ontario.
We were established by the Ontario Institute for Cancer Research (OICR) to support commercialization, technology transfer, and development activities. OICR conducts and enables world-class cancer research, filling a critical role as a pan-provincial connector of oncology researchers, resources and cancer innovation development. Together with OICR, we drive a shared vision to attract more R&D investment in Ontario and help the best oncology innovations reach the market and save lives.
FACIT is funded in part by the Government of Ontario through OICR